Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

663 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characteristics of hepatocellular carcinoma nodules newly detected by computed tomography during arteriography and arterial portography: preliminary report of a randomized controlled trial.
Ohki T, Tateishi R, Akahane M, Shiina S, Yamashiki N, Mikami S, Enooku K, Goto E, Masuzaki R, Kondo Y, Goto T, Inoo S, Ohtomo K, Omata M, Yoshida H, Koike K. Ohki T, et al. Among authors: mikami s. Hepatol Int. 2012 Jun;6(3):639-45. doi: 10.1007/s12072-011-9310-y. Epub 2011 Aug 31. Hepatol Int. 2012. PMID: 22020826
IGF-II Producing Hepatocellular Carcinoma Treated with Sorafenib: Metabolic Complications and a Foresight to Molecular Targeting Therapy to the IGF Signal.
Okushin K, Asaoka Y, Fukuda I, Fujiwara N, Minami T, Sato M, Mikami S, Uchino K, Enooku K, Kondo Y, Tateishi R, Goto T, Shiina S, Yoshida H, Koike K. Okushin K, et al. Among authors: mikami s. Case Rep Gastroenterol. 2012 Sep;6(3):784-9. doi: 10.1159/000346462. Epub 2012 Dec 22. Case Rep Gastroenterol. 2012. PMID: 23341802 Free PMC article.
CT with hepatic arterioportography as a pretreatment examination for hepatocellular carcinoma patients: a randomized controlled trial.
Ohki T, Tateishi R, Akahane M, Mikami S, Sato M, Uchino K, Arano T, Enooku K, Kondo Y, Yamashiki N, Goto T, Shiina S, Yoshida H, Matsuyama Y, Omata M, Ohtomo K, Koike K. Ohki T, et al. Among authors: mikami s. Am J Gastroenterol. 2013 Aug;108(8):1305-13. doi: 10.1038/ajg.2013.109. Epub 2013 Apr 30. Am J Gastroenterol. 2013. PMID: 23629602 Free PMC article. Clinical Trial.
Changes in risk of immediate adverse reactions to iodinated contrast media by repeated administrations in patients with hepatocellular carcinoma.
Fujiwara N, Tateishi R, Akahane M, Taguri M, Minami T, Mikami S, Sato M, Uchino K, Enooku K, Kondo Y, Asaoka Y, Yamashiki N, Goto T, Shiina S, Yoshida H, Ohtomo K, Koike K. Fujiwara N, et al. Among authors: mikami s. PLoS One. 2013 Oct 2;8(10):e76018. doi: 10.1371/journal.pone.0076018. eCollection 2013. PLoS One. 2013. PMID: 24098420 Free PMC article.
Cause-specific mortality associated with aging in patients with hepatocellular carcinoma undergoing percutaneous radiofrequency ablation.
Fujiwara N, Tateishi R, Kondo M, Minami T, Mikami S, Sato M, Uchino K, Enooku K, Masuzaki R, Nakagawa H, Kondo Y, Asaoka Y, Shiina S, Yoshida H, Koike K. Fujiwara N, et al. Among authors: mikami s. Eur J Gastroenterol Hepatol. 2014 Sep;26(9):1039-46. doi: 10.1097/MEG.0000000000000161. Eur J Gastroenterol Hepatol. 2014. PMID: 25051219
663 results